Factors associated with seasonal influenza and HPV vaccination uptake among different ethnic groups in Arab and Jewish society in Israel.

Publisher: BioMed Central Country of Publication: England NLM ID: 101147692 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-9276 (Electronic) Linking ISSN: 14759276 NLM ISO Abbreviation: Int J Equity Health Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2002-

Arabs*/psychology ; Arabs*/statistics & numerical data ; Influenza Vaccines*/administration & dosage ; Jews*/psychology ; Jews*/statistics & numerical data ; Mothers*/psychology ; Mothers*/statistics & numerical data ; Papillomavirus Vaccines*/administration & dosage ; Vaccination*/statistics & numerical data; Adolescent ; Child ; Cross-Sectional Studies ; Female ; Health Knowledge, Attitudes, Practice/ethnology ; Humans ; Influenza, Human/ethnology ; Influenza, Human/prevention & control ; Israel ; Male ; Papillomavirus Infections/ethnology ; Papillomavirus Infections/prevention & control ; Seasons

Background: Parents in the Arab population of Israel are known to be "pro-vaccination" and vaccinate their children at higher rates than the Jewish population, specifically against human papilloma virus (HPV) and seasonal influenza.
Objectives: This study seeks to identify and compare variables associated with mothers' uptake of two vaccinations, influenza and HPV, among different subgroups in Arab and Jewish society in Israel.
Methods: A cross-sectional study of the entire spectrum of the Israeli population was conducted using a stratified sample of Jewish mothers (n = 159) and Arab mothers (n = 534) from different subgroups: Muslim, Christian, Druse and Northern Bedouins. From March 30, 2019 through October 20, 2019, questionnaires were distributed manually to eighth grade pupils (13-14 years old) who had younger siblings in second (7-8 years old) or third (8-9 years old) grades.
Results: Arab mothers exhibited a higher rate of uptake for both vaccinations (p < .0001, HPV - 90%; influenza - 62%) than Jewish mothers (p = 0.0014, HPV - 46%; influenza - 34%). Furthermore, results showed that HPV vaccination uptake is significantly higher than seasonal influenza vaccination uptake in both populations. Examination of the different ethnic subgroups revealed differences in vaccination uptake. For both vaccinations, the Northern Bedouins exhibited the highest uptake rate of all the Arab subgroups (74%), followed by the Druse (74%) and Muslim groups (60%). The Christian Arab group exhibited the lowest uptake rate (46%). Moreover, the uptake rate among secular Jewish mothers was lower than in any of the Arab groups (38%), though higher than among religious/traditional Jewish mothers, who exhibited the lowest uptake rate (26%). A comparison of the variables associated with mothers' vaccination uptake revealed differences between the ethnic subgroups. Moreover, the findings of the multiple logistic regression revealed the following to be the most significant factors in Arab mothers' intake of both vaccinations: school-located vaccination and mothers' perceived risk and perceived trust in the system and in the family physician. These variables are manifested differently in the different ethnic groups.
Conclusions: This research shows that all Arabs cannot be lumped together as one monolithic group in that they exhibit major differences according to religion, education and access to information. Ranking of variables associated with uptake of the two vaccines can provide decision-makers an empirical basis for tailoring appropriate and specific interventions to each subgroup to achieve the highest vaccine uptake rate possible. Media campaigns targeting the Arab population should be segmented to appeal to the various sub-groups according to their viewpoints, needs and health literacy.
(© 2021. The Author(s).)

Vaccine. 2018 Dec 18;36(52):8062-8068. (PMID: 30473184)
J Health Commun. 2018;23(5):413-421. (PMID: 29589807)
Prev Med. 2017 Feb;95:26-37. (PMID: 27932052)
Int J Equity Health. 2020 Apr 25;19(1):55. (PMID: 32334577)
J Pediatr Nurs. 2016 May-Jun;31(3):293-8. (PMID: 26850937)
Papillomavirus Res. 2016 Dec;2:46-51. (PMID: 29074185)
Vaccine. 2019 Apr 3;37(15):2043-2050. (PMID: 30871929)
J Pediatric Infect Dis Soc. 2020 Mar 19;9(Supplement_1):S19-S23. (PMID: 32191311)
J Med Internet Res. 2018 Oct 09;20(10):e11667. (PMID: 30305264)
Am J Prev Med. 2018 Jan;54(1):20-27. (PMID: 29074320)
Isr J Health Policy Res. 2016 Apr 04;5:13. (PMID: 27051517)
Eur J Neurol. 2010 Jul;17(7):e52. (PMID: 20402758)
Vaccine. 2020 Jan 22;38(4):709-711. (PMID: 31836257)
JAMA Pediatr. 2014 Jan;168(1):76-82. (PMID: 24276343)
N Engl J Med. 2007 May 10;356(19):1928-43. (PMID: 17494926)
Hum Vaccin Immunother. 2017 Mar 4;13(3):701-702. (PMID: 27808587)
Int J Med Educ. 2011 Jun 27;2:53-55. (PMID: 28029643)
Scand J Public Health. 2015 Jun;43(4):408-14. (PMID: 25754868)
MMWR Morb Mortal Wkly Rep. 2017 Nov 03;66(43):1171-1177. (PMID: 29095807)
Hum Vaccin Immunother. 2019;15(1):121-133. (PMID: 30199302)
J Adolesc Health. 2013 Nov;53(5):623-9. (PMID: 23871803)
Arch Dis Child. 2005 Jan;90(1):36-40. (PMID: 15613508)
Vaccines (Basel). 2020 Mar 30;8(2):. (PMID: 32235481)
Clin Ther. 2014 Jan 1;36(1):24-37. (PMID: 24417783)
CMAJ. 2012 Oct 16;184(15):1673-81. (PMID: 22966054)
J Med Internet Res. 2019 May 17;21(5):e13373. (PMID: 31102371)
Lancet Infect Dis. 2015 May;15(5):565-80. (PMID: 25744474)
Sociol Health Illn. 2008 Sep;30(6):886-99. (PMID: 18761509)
Vaccine. 2015 Apr 8;33(15):1802-7. (PMID: 25744225)
Soc Sci Med. 2019 Jan;221:87-94. (PMID: 30576982)
Hum Vaccin Immunother. 2019;15(7-8):1615-1627. (PMID: 30633623)
Hum Vaccin Immunother. 2012 Mar;8(3):293-301. (PMID: 22327490)
Hum Vaccin Immunother. 2020 Jul 2;16(7):1611-1622. (PMID: 32429731)
J Racial Ethn Health Disparities. 2020 Apr;7(2):298-304. (PMID: 31721110)
Acad Pediatr. 2017 Sep - Oct;17(7):778-784. (PMID: 28359835)
Lancet. 2006 Mar 25;367(9515):987-91. (PMID: 16564360)
Health Commun. 2019 Jan;34(1):21-30. (PMID: 29053369)
Soc Sci Med. 2013 Apr;82:115-25. (PMID: 23337830)
Lancet Infect Dis. 2012 Aug;12(8):627-34. (PMID: 22445354)
Nurs Outlook. 2015 Nov-Dec;63(6):680-90. (PMID: 26362946)
Trop Med Infect Dis. 2020 Apr 09;5(2):. (PMID: 32283644)
J Adolesc Health. 2015 May;56(5 Suppl):S47-53. (PMID: 25863555)
Vaccine. 2011 Feb 1;29(6):1173-9. (PMID: 21167862)
Korean J Anesthesiol. 2017 Aug;70(4):407-411. (PMID: 28794835)
Vaccine. 2014 Apr 17;32(19):2150-9. (PMID: 24598724)
Lancet. 2020 Sep 26;396(10255):898-908. (PMID: 32919524)
Soc Sci Med. 2016 Jun;159:116-26. (PMID: 27180256)
Soc Sci Med. 2006 Feb;62(4):987-97. (PMID: 16139937)
Lancet Infect Dis. 2012 Jan;12(1):36-44. (PMID: 22032844)
Ethn Health. 2016 Oct;21(5):439-51. (PMID: 26304468)
Hum Vaccin Immunother. 2019;15(12):3009-3015. (PMID: 31339452)
Br J Cancer. 2017 Oct 10;117(8):1121-1127. (PMID: 28829766)
Health Promot Int. 2019 Jun 1;34(3):581-590. (PMID: 29590344)
Clin Pediatr (Phila). 2013 Mar;52(3):231-40. (PMID: 23362316)
Account Res. 2012;19(2):65-88. (PMID: 22375842)
BMJ Open. 2015 May 19;5(5):e006422. (PMID: 25991445)
J Infect Public Health. 2018 Mar - Apr;11(2):153-155. (PMID: 28988775)
BMC Health Serv Res. 2019 Jun 24;19(1):407. (PMID: 31234842)
J Epidemiol Community Health. 2009 Dec;63(12):1010-5. (PMID: 19762455)
J Adolesc Health. 2007 Jun;40(6):572.e1-8. (PMID: 17531765)
Womens Health Issues. 2015 Jan-Feb;25(1):56-62. (PMID: 25498764)
Clin Infect Dis. 2019 Nov 27;69(12):2153-2161. (PMID: 30753347)
Vaccine. 2019 Feb 21;37(9):1168-1173. (PMID: 30709722)
Hum Vaccin Immunother. 2019;15(7-8):1745-1751. (PMID: 30951396)
J Pediatr Adolesc Gynecol. 2012 Jun;25(3):218-20. (PMID: 22578484)
J Sch Health. 2019 Dec;89(12):1004-1012. (PMID: 31612491)
Hum Vaccin Immunother. 2017 Sep 2;13(9):2102-2110. (PMID: 28696824)
PLoS One. 2020 Aug 20;15(8):e0237734. (PMID: 32817681)
Med Care. 2013 Feb;51(2):151-7. (PMID: 23132201)
Int Rev Immunol. 2020;39(1):21-36. (PMID: 31707873)
Am J Infect Control. 2017 Mar 1;45(3):267-271. (PMID: 27856072)
J Immigr Minor Health. 2013 Aug;15(4):732-40. (PMID: 23081659)
J Am Med Inform Assoc. 2021 Aug 12;:. (PMID: 34383916)
Vaccine. 2020 Jan 3;38(1):29-38. (PMID: 31611101)
J Paediatr Child Health. 2011 Dec;47(12):888-92. (PMID: 22171831)
Med Anthropol. 2016 May-Jun;35(3):291-304. (PMID: 26786292)
NPJ Vaccines. 2020 Mar 13;5(1):22. (PMID: 32194999)

Keywords: Arab population of Israel; Decision-making; Ethnicity; Health orientation; Human papillomavirus (HPV); School-located vaccination program; Seasonal influenza; Social marketing; Trust; Vaccinations

0 (Influenza Vaccines)
0 (Papillomavirus Vaccines)

Date Created: 20210908 Date Completed: 20211006 Latest Revision: 20211006

20231215

PMC8423338

10.1186/s12939-021-01523-1

34493294